Ledger.Open graph →
SEC Form D · filed October 18, 2019

Icosavax, Inc

Offering
$51.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Seattle, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jason A. Hafler · Seattle, WADirectorEric A. Moessinger · Seattle, WADirectorMark A. Mcdade · Seattle, WADirectorTerry A. Gould · Seattle, WADirectorNiranjan A. Kanesa-Thasan · Seattle, WAExecAdam K. Simpson · San Diego, CAExec · DirectorCharles A. Richardson · Seattle, WAExecDouglas A. Holtzman · Seattle, WAExecTadataka Yamada, M.D · Seattle, WADirectorTerry A. Gould · Seattle, WADirectorJason A. Hafler · Seattle, WADirectorEric A. Moessinger · Seattle, WADirectorNiranjan A. Kanesa-Thasan · Seattle, WAExecAdam K. Simpson · Seattle, WAExec · DirectorMark A. Mcdade · Seattle, WADirectorCharles A. Richardson · Seattle, WAExecDouglas A. Holtzman · Seattle, WAExecTadataka Yamada, M.D · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗